Cita APA

Belcaid, Z., Berrevoets, C., Choi, J., van Beelen, E., Stavrakaki, E., Pierson, T., . . . Lamfers, M. L. M. (2020). Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapy. Neurooncol Adv.

Citación estilo Chicago

Belcaid, Zineb, et al. "Low-dose Oncolytic Adenovirus Therapy Overcomes Tumor-induced Immune Suppression and Sensitizes Intracranial Gliomas to Anti-PD-1 Therapy." Neurooncol Adv 2020.

Cita MLA

Belcaid, Zineb, et al. "Low-dose Oncolytic Adenovirus Therapy Overcomes Tumor-induced Immune Suppression and Sensitizes Intracranial Gliomas to Anti-PD-1 Therapy." Neurooncol Adv 2020.